These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1378609)

  • 21. Lidocaine increases the proarrhythmic effects of monophasic but not biphasic shocks.
    Sims JJ; Miller AW; Ujhelyi MR
    J Cardiovasc Electrophysiol; 2001 Dec; 12(12):1363-8. PubMed ID: 11797993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The implantable automatic cardioverter-defibrillator].
    Klein H; Tröster J; Trappe HJ; Becht I; Siclari F
    Herz; 1990 Apr; 15(2):111-25. PubMed ID: 2188891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of electrical pacing and automatic cardioversion defibrillation for normal cardiac function recovery.
    Pekarsky V; Astrakhantsev Y; Belenkov Y; Gimrikh E; Oferkin A; Maslov M; Popov S; Pekarskaya M; Markov V; Vasiltsev Y
    Pacing Clin Electrophysiol; 1986 Nov; 9(6 Pt 2):1349-55. PubMed ID: 2432561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmic complications of electrical cardioversion: relationship to shock energy.
    Gallagher MM; Yap YG; Padula M; Ward DE; Rowland E; Camm AJ
    Int J Cardiol; 2008 Jan; 123(3):307-12. PubMed ID: 17395302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode.
    Zipes DP; Jackman WM; Heger JJ; Chilson DA; Browne KF; Naccarelli GV; Rahilly GT; Prystowsky EN
    Am Heart J; 1982 May; 103(5):789-94. PubMed ID: 7072583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of antiarrhythmic drug therapy on the incidence of shocks in patients who receive an implantable cardioverter defibrillator after a single episode of sustained ventricular tachycardia/fibrillation.
    Kou WH; Kirsh MM; Bolling SF; Stirling M; Kadish AH; De Buitleir M; Calkins H; Lewis RR; Morady F
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1586-92. PubMed ID: 1721147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of dual electrode systems for endocardial cardioversion of ventricular tachycardia: a prospective randomized crossover trial.
    Saksena S; An H
    Am Heart J; 1990 Jan; 119(1):15-22. PubMed ID: 2404386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sustained ventricular tachycardia: low-energy transcatheter internal cardioversion. Efficacy, reliability and tolerance in comparison with ventricular burst].
    Vergara G; Disertori M; Inama G; Guarnerio M; Stirpe E; Furlanello F
    G Ital Cardiol; 1985 Sep; 15(9):862-72. PubMed ID: 4085732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A focused investigation of expedited, stack of three shocks versus chest compressions first followed by single shocks for monitored ventricular fibrillation/ventricular tachycardia cardiopulmonary arrest in an in-hospital setting.
    Davis D; Aguilar SA; Sell R; Minokadeh A; Husa R
    J Hosp Med; 2016 Apr; 11(4):264-8. PubMed ID: 26510012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracardiac atrial defibrillation.
    Dosdall DJ; Ideker RE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S51-6. PubMed ID: 17336885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular tachycardia rate and morphology determine energy and current requirements for transthoracic cardioversion.
    Kerber RE; Kienzle MG; Olshansky B; Waldo AL; Wilber D; Carlson MD; Aschoff AM; Birger S; Fugatt L; Walsh S
    Circulation; 1992 Jan; 85(1):158-63. PubMed ID: 1728445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation during ventricular defibrillation in open-chest dogs. Evidence of complete cessation and regeneration of ventricular fibrillation after unsuccessful shocks.
    Chen PS; Shibata N; Dixon EG; Wolf PD; Danieley ND; Sweeney MB; Smith WM; Ideker RE
    J Clin Invest; 1986 Mar; 77(3):810-23. PubMed ID: 3949979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical mapping of ventricular defibrillation in isolated swine right ventricles: demonstration of a postshock isoelectric window after near-threshold defibrillation shocks.
    Wang NC; Lee MH; Ohara T; Okuyama Y; Fishbein GA; Lin SF; Karagueuzian HS; Chen PS
    Circulation; 2001 Jul; 104(2):227-33. PubMed ID: 11447091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of multiple shocks on canine cardiac defibrillation.
    Flaker G; Schuder J; McDaniel W
    Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 1):1580-4. PubMed ID: 1704508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epicardial activation after unsuccessful defibrillation shocks in dogs.
    Shibata N; Chen PS; Dixon EG; Wolf PD; Danieley ND; Smith WM; Ideker RE
    Am J Physiol; 1988 Oct; 255(4 Pt 2):H902-9. PubMed ID: 3177679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of defibrillation. Critical points and the upper limit of vulnerability.
    Walcott GP; Walcott KT; Ideker RE
    J Electrocardiol; 1995; 28 Suppl():1-6. PubMed ID: 8656095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic inquiry into decrease in probability of defibrillation success with increase in complexity of preshock reentrant activity.
    Hillebrenner MG; Eason JC; Trayanova NA
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H909-17. PubMed ID: 14604852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pacing rate and timing of defibrillation shock on the relation between the defibrillation threshold and the upper limit of vulnerability in open chest dogs.
    Chen PS; Feld GK; Mower MM; Peters BB
    J Am Coll Cardiol; 1991 Nov; 18(6):1555-63. PubMed ID: 1939961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.